Table of Contents
ISRN Pharmaceutics
Volume 2011, Article ID 521353, 7 pages
http://dx.doi.org/10.5402/2011/521353
Research Article

Separation and Quantification of Eight Antidiabetic Drugs on A High-Performance Liquid Chromatography: Its Application to Human Plasma Assay

Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM University, Kattankulathur, Tamil Nadu 603203, India

Received 30 March 2011; Accepted 5 May 2011

Academic Editor: N. El-Enany

Copyright © 2011 Karunanidhi S. Lakshmi and Tirumala Rajesh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Craig and R. E. Stitzel, Modern Pharmacology with Clinical Applications, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 6th edition, 2008.
  2. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. Willson, J. E. Cobb, D. J. Cowan et al., “The structure—activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones,” Journal of Medicinal Chemistry, vol. 39, no. 3, pp. 665–668, 1996. View at Google Scholar · View at Scopus
  4. P. W. Young, D. R. Buckle, B. C. C. Cantello et al., “Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor γ,” Journal of Pharmacology and Experimental Therapeutics, vol. 284, no. 2, pp. 751–759, 1998. View at Google Scholar · View at Scopus
  5. R. S. Satoskar, S. D. Bhanbarkar, and N. Nirmala, Pharmacology & Pharmacotherapeutics, Popular Prakashan, India, 17th edition, 2001.
  6. J. Fuhlendorff, P. Rorsman, H. Kofod et al., “Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes,” Diabetes, vol. 47, no. 3, pp. 345–351, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. Karara, B. E. Dunning, and J. F. McLeod, “The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects,” Journal of Clinical Pharmacology, vol. 39, no. 2, pp. 172–179, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. L. M. Keilson, S. Mather, Y. H. Walter, S. Subramanian, and J. F. McLeod, “Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 3, pp. 1081–1086, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Venkatesh, T. Harisudhan, H. Choudhury, R. Mullangi, and N. R. Srinivas, “Simultaneous estimation of six anti-diabetic drugs—glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay,” Biomedical Chromatography, vol. 20, no. 10, pp. 1043–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Yao, Y. Q. Shi, Z. R. Li, and S. H. Jin, “Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs,” Journal of Chromatography B, vol. 853, no. 1-2, pp. 254–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Aburuz, J. S. Millership, and J. C. McElnay, “The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma,” Journal of Chromatography B, vol. 817, no. 2, pp. 277–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-C. Chou, M.-R. Lee, F.-C. Cheng, and D.-Y. Yang, “Solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry for determination of trace rosiglitazone in urine,” Journal of Chromatography A, vol. 1097, no. 1-2, pp. 74–83, 2005. View at Publisher · View at Google Scholar
  13. Z. J. Lin, W. Ji, D. Desai-Krieger, and L. Shum, “Simultaneous determination of pioglitazone and its two active metabolites in human plasma by LC-MS/MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 33, no. 1, pp. 101–108, 2003. View at Publisher · View at Google Scholar
  14. C.-G. Ding, Z. Zhou, Q.-H. Ge, X.-J. Zhi, and L.-L. Ma, “Simultaneous determination of metformin and glipizide in human plasma by liquid chromatography-tandem mass spectrometry,” Biomedical Chromatography, vol. 21, no. 2, pp. 132–138, 2007. View at Publisher · View at Google Scholar
  15. G. Ling, J. Sun, J. Tang, X. Xu, Y. Sun, and Z. He, “Liquid chromatography-electrospray ionization mass spectrometric method for determination of gliclazide in human plasma,” Analytical Letters, vol. 39, no. 7, pp. 1381–1391, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Niopas and A. C. Daftsios, “A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 3-4, pp. 653–657, 2002. View at Publisher · View at Google Scholar
  17. C. Gedeon, B. Kapur, K. Aleksa, and G. Koren, “A simple and rapid HPLC method for the detection of glyburide in plasma original research communication (analytical),” Clinical Biochemistry, vol. 41, no. 3, pp. 167–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Malli, E. Gikas, A. Vavagiannis et al., “Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent,” Analytica Chimica Acta, vol. 599, no. 1, pp. 143–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Sankalia, M. G. Sankalia, V. B. Sutariya, and R. C. Mashru, “Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 1, pp. 196–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Yardımcı and N. Özaltın, “Simultaneous determination of rosiglitazone and metformin in pharmaceutical preparations by LC,” Chromatographia, vol. 66, no. 7-8, pp. 589–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Yardımcı, N. Özaltın, and A. Gürlek, “Simultaneous determination of rosiglitazone and metformin in plasma by gradient liquid chromatography with UV detection,” Talanta, vol. 72, no. 4, pp. 1416–1422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. L. Kolte, B. B. Raut, A. A. Deo, M. A. Bagool, and D. B. Shinde, “Simultaneous high-performance liquid chromatographic determination of pioglitazone and metformin in pharmaceutical-dosage form,” Journal of Chromatographic Science, vol. 42, no. 1, pp. 27–31, 2004. View at Google Scholar · View at Scopus
  23. C.-G. Ding, Z. Zhou, Q.-H. Ge, X.-J. Zhi, and L.-L. Ma, “Simultaneous determination of metformin and glipizide in human plasma by liquid chromatography-tandem mass spectrometry,” Biomedical Chromatography, vol. 21, no. 2, pp. 132–138, 2007. View at Publisher · View at Google Scholar
  24. H. N. Mistri, A. G. Jangid, and P. S. Shrivastav, “Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 45, no. 1, pp. 97–106, 2007. View at Publisher · View at Google Scholar
  25. K. Karthrik, G. S. Subramanian, C. M. Rao et al., “Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 4, pp. 421–425, 2008. View at Google Scholar · View at Scopus
  26. K. S. Lakshmi, T. Rajesh, and S. Sharma, “Determination of pioglitazone and glimepiride in pharmaceutical formulations and rat plasma by RP-LC,” International Journal of PharmTech Research, vol. 1, no. 3, pp. 496–499, 2009. View at Google Scholar · View at Scopus
  27. A. Gumieniczeka, H. Hopkala, and A. Bereckaa, “Reversed-phase thin-layer chromatography of three new oral antidiabetics and densitometric determination of pioglitazone,” Journal of Liquid Chromatography & Related Technologies, vol. 27, no. 13, pp. 2057–2070, 2004. View at Publisher · View at Google Scholar
  28. M. J. Sáiz-Abajo, J. M. González-Sáiz, and P. Consuelo, “Multi-objective optimisation strategy based on desirability functions used for chromatographic separation and quantification of L-proline and organic acids in vinegar,” Analytica Chimica Acta, vol. 528, no. 1, pp. 63–76, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Guidance for the Industry: Analytical Method Validation, US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, Md, USA, 2000.